Clinical Trials ART - Kaisernetwork.org

Clinical Trials ART 7/24/2007
International AIDS Society and Australasian Society for HIV Medicine, Sydney, Australia

Subscribe to Podcasts from IAS 2007

For more information on this session, please see the conference Programme-at-a-Glance page.

Full version:

Video

Podcast

Transcript

Speakers for this session:

Co-Chairs

Jose R Arribas, M.D.
Hospital La Paz, Autonoma University School of Medicine
Spain
Christine Katlama, M.D.
Head
AIDS Clinical Research Unit, Pitié-Salpêtrière Hospital
France

Video

Comparison of 48-Week Efficacy and Safety of Darunavir/Ritonavir (DRV/r) with Lopinavir/Ritonavir (LPV/r) in LPV/R-naïve, Treatment-Experienced Patients: a Randomised, Controlled Phase III Trial (TITAN)

Jose Valdez-Madruga, M.D.

Centro de Referência e Treinamento DST/AIDS

Brazil

Video |

Slides |

Abstract

ACTG 5211: Phase II Study of the Safety and Efficacy of Vicriviroc (VCV) in HIV-Infected Treatment-Experienced Subjects: 48 Week Results

Roy Gulick, M.D., M.P.H.

Associate Professor of Medicine
Weill-Cornell Medical College

United States

Video |

Slides |

Abstract

The Integrase Inhibitor Raltegravir Alters Viral Decay Kinetics of HIV, Significantly Reducing the Second Phase and Challenging Current Hypotheses of Viral Replication

John M Murray, B.Sc.(Hons), M.Sc., Ph.D.

National Centre in HIV Epidemiology and Clinical Research

Australia

Video |

Slides |

Abstract

Rapid Onset and Durable Antiretroviral Effect of Raltegravir (MK-0518), a Novel HIV-1 Integrase Inhibitor, as Part of Combination ART in Treatment HIV-1 Infected Patients: 48-Week Data

Martin Markowitz, M.D.

Principal Investigator, Aaron Diamond Professor
Aaron Diamond AIDS Research Center

United States

Video |

Slides |

Abstract

The Metabolic Profile of TMC278, an Investigational Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)

Kiat Ruxrungtham, M.D.

Thai Red Cross AIDS Research Centre

Thailand

Video |

Slides |

Abstract

Potent Antiretroviral Activity of the Once-Daily CCR5 Antagonist INCB009471 Over 14 Days of Monotherapy

Calvin Cohen, M.D., M.Sc.

Research Director

Community Research Initiative of New England

United States

Video |

Slides |

Abstract

EMAIL ALERTS
Sign up for email alerts and stay informed about upcoming HealthCasts, and the latest health policy issues, news and events.

FAQs

More...

CONTACT US
Contact us by email with any comments, problems, suggestions.
Call the kaisernetwork.org Help Desk at 202-347-5270.

...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ......